Angelo Sambunaris

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

Andrew A. Nierenberg, John H. Greist, Craig Mallinckrodt et al. · Current Medical Research and Opinion · 2007 · 132 citations

Medicine, Pharmacotherapy, Psychiatry +15

A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder

Angelo Sambunaris, Anjana Bose, Carl Gommoll et al. · Journal of Clinical Psychopharmacology · 2013 · 90 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder

Manisha Madhoo, Richard S.E. Keefe, Robert M. Roth et al. · Neuropsychopharmacology · 2013 · 73 citations

Medicine, Pharmacology, Psychiatry +16

A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram

Madhukar H. Trivedi, Andrew J. Cutler, Cynthia Richards et al. · The Journal of Clinical Psychiatry · 2013 · 58 citations

Medicine, Pharmacology, Psychiatry +17

Development of new antidepressants.

Angelo Sambunaris, J K Hesselink, R. M. Pinder et al. · PubMed · 1997 · 44 citations

Medicine, Pharmacology, Pharmacotherapy +17